María José Besso - Search Results

Year	Number of Results
2014	1
2015	1
2016	2
2017	2
2019	2
2020	2
2021	1
2023	2
2024	2

1

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts.

Koi L, Bitto V, Weise C, Möbius L, Linge A, Löck S, Yaromina A, Besso MJ, Valentini C, Pfeifer M, Overgaard J, Zips D, Kurth I, Krause M, Baumann M. Koi L, et al. Among authors: besso mj. J Transl Med. 2023 Aug 26;21(1):576. doi: 10.1186/s12967-023-04439-2. J Transl Med. 2023. PMID: 37633930 Free PMC article.

2

Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer.

Schniewind I, Besso MJ, Klicker S, Schwarz FM, Hadiwikarta WW, Richter S, Löck S, Linge A, Krause M, Dubrovska A, Baumann M, Kurth I, Peitzsch C. Schniewind I, et al. Among authors: besso mj. Cancers (Basel). 2024 Feb 9;16(4):730. doi: 10.3390/cancers16040730. Cancers (Basel). 2024. PMID: 38398123 Free PMC article.

3

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.

Lüttich L, Besso MJ, Heiden S, Koi L, Baumann M, Krause M, Dubrovska A, Linge A, Kurth I, Peitzsch C. Lüttich L, et al. Among authors: besso mj. Cancers (Basel). 2021 Apr 14;13(8):1865. doi: 10.3390/cancers13081865. Cancers (Basel). 2021. PMID: 33919702 Free PMC article.

4

Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.

Besso MJ, Montivero L, Lacunza E, Argibay MC, Abba M, Furlong LI, Colas E, Gil-Moreno A, Reventos J, Bello R, Vazquez-Levin MH. Besso MJ, et al. Oncol Rep. 2020 Sep;44(3):873-886. doi: 10.3892/or.2020.7648. Epub 2020 Jun 16. Oncol Rep. 2020. PMID: 32705231 Free PMC article.

5

CDH1/E-cadherin and solid tumors. An updated gene-disease association analysis using bioinformatics tools.

Abascal MF, Besso MJ, Rosso M, Mencucci MV, Aparicio E, Szapiro G, Furlong LI, Vazquez-Levin MH. Abascal MF, et al. Among authors: besso mj. Comput Biol Chem. 2016 Feb;60:9-20. doi: 10.1016/j.compbiolchem.2015.10.002. Epub 2015 Nov 7. Comput Biol Chem. 2016. PMID: 26674224

6

E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.

Rosso M, Majem B, Devis L, Lapyckyj L, Besso MJ, Llauradó M, Abascal MF, Matos ML, Lanau L, Castellví J, Sánchez JL, Pérez Benavente A, Gil-Moreno A, Reventós J, Santamaria Margalef A, Rigau M, Vazquez-Levin MH. Rosso M, et al. Among authors: besso mj. PLoS One. 2017 Sep 21;12(9):e0184439. doi: 10.1371/journal.pone.0184439. eCollection 2017. PLoS One. 2017. PMID: 28934230 Free PMC article.

7

Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.

Mencucci MV, Lapyckyj L, Rosso M, Besso MJ, Belgorosky D, Isola M, Vanzulli S, Lodillinsky C, Eiján AM, Tejerizo JC, Gonzalez MI, Zubieta ME, Vazquez-Levin MH. Mencucci MV, et al. Among authors: besso mj. Front Oncol. 2020 Mar 27;10:283. doi: 10.3389/fonc.2020.00283. eCollection 2020. Front Oncol. 2020. PMID: 32292715 Free PMC article.

8

Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events.

Matos ML, Lapyckyj L, Rosso M, Besso MJ, Mencucci MV, Briggiler CI, Giustina S, Furlong LI, Vazquez-Levin MH. Matos ML, et al. Among authors: besso mj. J Cell Physiol. 2017 Jun;232(6):1368-1386. doi: 10.1002/jcp.25622. Epub 2016 Dec 29. J Cell Physiol. 2017. PMID: 27682981

9

Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways.

Besso MJ, Rosso M, Lapyckyj L, Moiola CP, Matos ML, Mercogliano MF, Schillaci R, Reventos J, Colas E, Gil-Moreno A, Wernicke A, Orti R, Vazquez-Levin MH. Besso MJ, et al. Front Oncol. 2024 Jan 23;13:1322204. doi: 10.3389/fonc.2023.1322204. eCollection 2023. Front Oncol. 2024. PMID: 38322279 Free PMC article.

10

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways.

Besso MJ, Rosso M, Lapyckyj L, Moiola CP, Matos ML, Mercogliano MF, Schillaci R, Reventos J, Colas E, Gil-Moreno A, Wernicke A, Orti R, Vazquez-Levin MH. Besso MJ, et al. Front Oncol. 2019 Dec 6;9:1306. doi: 10.3389/fonc.2019.01306. eCollection 2019. Front Oncol. 2019. PMID: 31867269 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year